Role of Artificial Intelligence in Kidney Disease
Epidemiology of kidney disease including statistics on ESRD patients, dialysis treatments, and medical expenses in China. Presentation on AI's role in nephrology & development of renal AI medical devices.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
FGAI4H-O-031-A01 Berlin, 31 May 2 June 2022 Source: Ark Health Solution (Shanghai) Ltd Title: New TG Proposal on Nephrology: Role of Artificial Intelligence in Kidney Disease - Att.1 Presentation Purpose: Discussion Michelle Yun Lu Ark Health Solution (Shanghai) Ltd. China This PPT contains a presentation of FGAI4H-O-031. Email: mylu78@protonmail.com Contact: Abstract:
Role of Artificial Intelligence in Kidney Disease Ark Health Solution ( Shanghai) Ltd. Michelle Yun Lu
Epidemiology: Kidney Disease Kidney disease had affected 750 million people globally. (GBD 2015) End-stage renal disease (ESRD) refers to the terminal stage of various chronic kidney diseases. The total number of ESRD patients in China is about 220,000, which is a large number. ESRDonly be treated with a kidney transplant ordialysis.
Over 272,000 patients receive peritoneal dialysis worldwide. world. 1 Peritoneal dialysis is predicted to increase at a rate of 8% around the 2 Dialysis There are 326,000 dialysis patients in mainland China. 3 In China, 280,000 patients received hemodialysis. ( 86% of the dialysis population). 4 In China, 46,000 patients received peritoneal dialysis. 5
DIALYSIS IN CHINA 1 2 3 The patient is undergoing hemodialysis treatment. Location:Hospital Frequency:2/3 times a week The patient injected Peritoneal Dialysis Solution into the body. Location:Home Frequency: 4bags/day The chronic kidney disease patient takes various types of drugs. Location:Home Frequency: multiple times/day Average MedicalExpenses: 100,000 RMB $15,000 Average MedicalExpenses: 100,000 RMB $15,000 Average MedicalExpenses: 30,000 RMB $5,000
WhoWe Are Focuses on the chronic kidney disease big data platform and renal artificial intelligence development. 1 Our data platform has cooperated with nephrology departments in China. 2 LeverageAI techniquetodevelopreliablerenal medicaldevicesforkidneydiseases. 3
Artificial Intelligence R&D in Dialysis Related Medical Devices Daily Management of Dialysis Patients Clinical Data of Nephrology Machine Learning Using medicaldata for Industry-academia- research cooperation, and R&D of medical AI and devices,etc. Products: Digital therapy intervention system combining software and hardware with intelligentalgorithms (hardware&software, diet,etc.) R&D: research on artificialintelligence algorithms in nephrology Invention patents: Home dialysis assistedmanagement system,etc.
Existing Products &Patents AI-Based Renal DialysisHealth Management System AI-Based CKD-MBDAnalysis Patent Certificate
Smart Kidney Dialysis Health Management Device Development Process & Milestones
